PSA
Also known as: Prostate-Specific Antigen
What Does PSA Measure?
Prostate-Specific Antigen (PSA) is a protein produced exclusively by prostate gland cells. A blood test measures the concentration of PSA in the bloodstream, expressed in nanograms per milliliter (ng/mL). PSA is naturally present in small amounts in healthy men, as it helps liquefy semen after ejaculation. Both normal prostate tissue and abnormal tissue — including cancerous cells — produce PSA, but cancerous or inflamed tissue tends to produce significantly higher amounts, causing PSA levels to rise in the blood.
Why Does PSA Matter?
PSA testing is primarily used as a screening tool for prostate cancer and to monitor men already diagnosed with or treated for prostate cancer. Elevated PSA levels can signal prostate cancer, benign prostatic hyperplasia (BPH), or prostatitis, prompting further investigation such as a biopsy or imaging. While PSA is the best available prostate cancer biomarker, it is not perfectly specific — many men with elevated PSA do not have cancer, and some with prostate cancer have normal PSA levels. When used alongside a digital rectal exam (DRE), PSA testing significantly improves early detection of clinically significant prostate cancer, enabling treatment at a more curable stage and reducing prostate cancer mortality.
Normal Ranges
Males
0–4.0 ng/mL (age-specific ranges: 40–49 years: 0–2.5 ng/mL; 50–59 years: 0–3.5 ng/mL; 60–69 years: 0–4.5 ng/mL; 70+ years: 0–6.5 ng/mL)
Females
Not applicable — women do not have a prostate gland
Children
Not applicable — PSA testing is not performed in children
Causes of High Levels
- Prostate cancer — malignant cells produce excess PSA, often causing significant elevation
- Benign prostatic hyperplasia (BPH) — non-cancerous prostate enlargement increases PSA production proportional to gland size
- Prostatitis — bacterial or non-bacterial inflammation of the prostate can sharply elevate PSA levels
- Recent ejaculation — sexual activity within 24–48 hours before testing can transiently raise PSA
- Urological procedures or trauma — prostate biopsy, cystoscopy, urinary catheterization, or vigorous rectal exam can release PSA into the bloodstream
- Urinary tract infection — infection involving the prostate area can temporarily increase PSA
Causes of Low Levels
- 5-alpha reductase inhibitors (finasteride, dutasteride) — medications for BPH or hair loss reduce PSA by approximately 50%, requiring adjusted interpretation
- Obesity — higher body fat is associated with hemodilution, which can artificially lower measured PSA concentrations
How to Improve Your PSA
Diet
- Increase tomato and tomato product consumption — lycopene, abundant in cooked tomatoes, is associated with reduced prostate cancer risk and may help moderate PSA levels
- Eat more cruciferous vegetables (broccoli, cauliflower, Brussels sprouts) — sulforaphane compounds support prostate cell health
- Include soy-based foods such as tofu and edamame — isoflavones have shown modest PSA-lowering effects in clinical studies
- Reduce red and processed meat intake — high consumption is linked to increased prostate cancer risk and elevated PSA
- Adopt a Mediterranean-style diet rich in fish, olive oil, fruits, and vegetables — associated with lower rates of aggressive prostate cancer
Supplements
- Lycopene 15–30 mg/day — antioxidant from tomatoes shown in some studies to reduce PSA progression
- Vitamin D3 1,000–2,000 IU/day — vitamin D deficiency is associated with more aggressive prostate cancer; supplementation may help normalize PSA trends
- Omega-3 fatty acids (EPA+DHA) 1,000–2,000 mg/day — anti-inflammatory effects may support prostate health
- Green tea extract (EGCG) 400–800 mg/day — polyphenols have demonstrated PSA-stabilizing properties in preliminary research
Related Biomarkers
Frequently Asked Questions
What PSA level should I be worried about?
A PSA above 4.0 ng/mL is traditionally considered elevated and warrants further evaluation, but context matters greatly. Men with PSA between 4–10 ng/mL have roughly a 25% chance of prostate cancer on biopsy, while those above 10 ng/mL have about a 50% chance. However, many doctors now consider values above 2.5–3.0 ng/mL in younger men (under 50) as potentially concerning. Rather than focusing on a single number, your doctor will also assess your PSA trend over time (PSA velocity), your free-to-total PSA ratio, prostate size, age, race, and family history before recommending next steps.
Can I have prostate cancer with a normal PSA?
Yes. Approximately 15–25% of men with PSA levels below 4.0 ng/mL are found to have prostate cancer on biopsy, and some of these cancers can be clinically significant. This is known as the 'PSA blind spot.' This is why PSA testing is often combined with a digital rectal exam (DRE), and why newer tests like the Prostate Health Index (PHI), 4Kscore, or MRI imaging may be recommended for men at higher risk even with a normal PSA. Regular monitoring and discussing your individual risk factors with your doctor is more informative than any single PSA result.
How often should I get a PSA test?
Guidelines vary by organization and individual risk. The American Cancer Society recommends that men discuss PSA screening starting at age 50 for average-risk men, age 45 for high-risk men (African Americans or those with a first-degree relative diagnosed with prostate cancer before age 65), and age 40 for very high-risk men (more than one first-degree relative with early prostate cancer). For men who choose to screen, testing is typically done annually or every 1–2 years depending on baseline PSA levels. Men with PSA below 1.0 ng/mL may only need testing every 2–4 years, while those with higher baseline values warrant annual monitoring.